The Weekly Roundup: February 10-14

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD

Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.

Developing Personalized Approaches for Atopic Dermatitis Treatment

Tina Bhutani-Jacques, MD, highlighted the importance of individualized and informative care while building trust among patients and caregivers.

Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

Information on TikTok About Spironolactone is Unreliable, New Study Finds

The top videos under the hashtag, #spironolactone” had low scores on the mDISCERN and GQS scales, according to Adam Friedman, MD, FAAD, senior author of the study.

Education Drives Success in Atopic Dermatitis Treatment

A recent expert discussion highlighted the importance of long-term planning, including when and how to adjust or transition therapies.

Botox Cosmetic: Ethics, Empowerment, and Innovation

Botox Cosmetic has evolved from its accidental discovery to a leading treatment in dermatology, balancing medical innovation with ethical considerations.

Practice What You Preach: A Clinician's Guide to Chemical Peels

Dobkin underwent the procedure in order to connect with his patients considering it for themselves.

Closing the Wound Care Gap: Addressing Disparities in Amputations and Limb Preservation

Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.

SBS 2025: Complete Conference Recap

Catch up on coverage from the 2025 South Beach Symposium held in Miami Beach, Florida.

Practical, Real-World Pearls for Managing Complex Atopic Dermatitis Cases

Lisa Weiss, MMSc, PA-C, and colleagues offered insights on managing severe atopic dermatitis cases with biologics, nonsteroidal treatments, and strategies for addressing physical and emotional impacts.

Journal Digest: February 12

This review of the latest dermatologic studies includes insights into endocrine, psychological, and nutritional aspects in women with hidradenitis suppurativa; forms of hair loss among individuals with anxiety disorder; and more.

Topical TCA and Methoxsalen Not Clinically Effective for Acral Vitiligo

Each treatment saw very mild clinical and dermatologic responses with low levels of patient satisfaction.

Expert Insights on Personalizing Atopic Dermatitis Treatment

New drugs targeting IL-4, IL-13, and IL-31 pathways provide options for tailored eczema treatments.

Reviewing Complex Cases: Special Issues in AD Comorbidities

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a woman aged 27 years who had eczematous lesions covering more than 20% of her BSA.

Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma

Trauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.

MOPD 2025: Complete Conference Recap

Catch up on coverage from the 2025 Masters of Pediatric Dermatology held in Miami Beach, Florida.

Should “Advanced Practice Provider” Represent Both PAs and NPs?

Uniting all professions should be the goal as it concerns the patient and the access to care.

Post-Hoc Analysis of ALLEGRO-2b/3 Trial Highlights Patient-Reported Outcome Improvements

Clinicians observed a positive relationship between scalp hair regrowth and downstream treatment benefits for patients with alopecia areata.

The Complex World of Urticaria: Insights from Jason Hawkes, MD, MS

Hawkes discusses urticaria subtypes, treatments, and emerging therapies like dupilumab and remibrutinib.

Balancing Biologics and Corticosteroids: Tailored Approaches for Managing Atopic Dermatitis

Alexandra Golant, MD, led a Dermatology Times Case-Based Roundtable® event that focused on advancing therapeutic strategies for atopic dermatitis.

POLL: Looking Ahead to Winter Clinical Hawaii 2025

Are you attending Winter Clinical Hawaii? Answer our poll below to let us know.

New Study Examines Connection Between Formulation and Benzene Levels in BPO Products

Barbieri et al evaluated product use, benzoyl peroxide concentration, days until expiration, and more.

Allergan Medical Institute to Launch 3 New US Training Centers for Clinicians

The state-of-the-art facilities in California, Georgia, and Texas will expand AMI’s curriculum to providers of all levels.

The Dermatology Industry Landscape: Unpacking Mergers and Acquisitions and Other Economic Movements

Explore 2025’s dermatology M&A trends, economic shifts, and key investment drivers shaping the industry's future.

Revolutionizing Telemedicine in Dermatological Care

Renata Block, MMS, PA-C, and Michael Rubio, PA-C discuss the complexities of developing a telehealth program in the world of dermatology.

Potential 2025 Tax Law Changes: What Dermatologists Should Know

Key 2025 tax law changes for dermatologists include expiring TCJA provisions, potential rate adjustments, and new deduction policies under Trump.

How Well Revolution Combines In-Person Care with Telehealth

Michael Rubio, PA-C talks with Renata Block, MMS, PA-C, about his virtual care platform and how it can expand access to care.

New Data on Bimekizumab’s Long-term HS Efficacy

Bimekizumab demonstrated long-term effectiveness in patients with HS, with over 85% maintaining response and reduced draining tunnels.

Tailoring Atopic Dermatitis Treatment to Meet Patient Needs

Adelaide A. Hebert, MD, FAAD, stressed the importance of educating patients, setting realistic expectations, and ensuring they adhere to AD treatment plans.

Nektar's Jonathan Zalevsky, PhD, Dives Into Rezpegaldesleukin Fast Track Designation for Atopic Dermatitis

Zalevsky shares insights into the implications of the designation and what it may mean for Rezpeg's development timeline.

Bridging Dermatology and Psychological Support

A global review found that skin condition advocacy groups offer diverse mental health resources, but accessibility gaps persist worldwide.